Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
January 10, 2002
Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children
R B Belshe, W C Gruber
Virology
|
October 1, 1993
Fiber gene and genomic origin of human adenovirus type 4
W C Gruber, D J Russell, C Tibbetts
The Journal of Infectious Diseases
|
June 1, 1995
Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin
B S Graham, Y W Tang, W C Gruber
Pediatric Research
|
March 1, 1987
Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat
W C Gruber, S Z Wilson, B J Throop, et al.
Pediatric Research
|
August 1, 1993
Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum
B S Graham, T H Davis, Y W Tang, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1995
Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections
K M Neuzil, W C Gruber, F Chytil, et al.
The Pediatric Infectious Disease Journal
|
December 31, 1997
Influenza virus infections in infants
W P Glezen, L H Taber, A L Frank, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1985
Single-dose pharmacokinetics of imipenem-cilastatin in neonates
W C Gruber, M A Rench, J A Garcia-Prats, et al.
The Journal of Pediatrics
|
March 1, 1994
Serum vitamin A levels in respiratory syncytial virus infection
K M Neuzil, W C Gruber, F Chytil, et al.
Vaccine
|
August 1, 1997
Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response
W C Gruber, P M Darden, J G Still, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
January 10, 2002
Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children
R B Belshe, W C Gruber
Virology
|
October 1, 1993
Fiber gene and genomic origin of human adenovirus type 4
W C Gruber, D J Russell, C Tibbetts
The Journal of Infectious Diseases
|
June 1, 1995
Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin
B S Graham, Y W Tang, W C Gruber
Pediatric Research
|
March 1, 1987
Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat
W C Gruber, S Z Wilson, B J Throop, et al.
Pediatric Research
|
August 1, 1993
Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum
B S Graham, T H Davis, Y W Tang, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1995
Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections
K M Neuzil, W C Gruber, F Chytil, et al.
The Pediatric Infectious Disease Journal
|
December 31, 1997
Influenza virus infections in infants
W P Glezen, L H Taber, A L Frank, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1985
Single-dose pharmacokinetics of imipenem-cilastatin in neonates
W C Gruber, M A Rench, J A Garcia-Prats, et al.
The Journal of Pediatrics
|
March 1, 1994
Serum vitamin A levels in respiratory syncytial virus infection
K M Neuzil, W C Gruber, F Chytil, et al.
Vaccine
|
August 1, 1997
Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response
W C Gruber, P M Darden, J G Still, et al.
Page
of 4